G Medical Innovations Holdings Ltd. Warrants (GMVDW)
$7.04
$1.58
(28.94%)
As on 22-Aug-2023 13:34EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
6 Years Aggregate
CFO
$-58.37 Mln
EBITDA
$-107.48 Mln
Net Profit
$-101.26 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
G Medical Innovations Holdings Ltd. Warrants (GMVDW)
| 750.2 | 75.6 | 413.9 | 122.3 | -- | -- | -- |
|
BSE Sensex*
| -12.4 | -4.9 | -1.8 | -9.4 | 3.2 | 5.0 | 10.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout G Medical Innovations Holdings Ltd. Warrants (GMVDW)
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The... company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel. Read more
-
Pres, CEO, MD & Exec. Director
Dr. Yacov Geva
-
Pres, CEO, MD & Exec. Director
Dr. Yacov Geva
-
Headquarters
Rehovot
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for G Medical Innovations Holdings Ltd. Warrants (GMVDW)
What is the current share price of G Medical Innovations Holdings Ltd Warrants (GMVDW) Today?
The share price of G Medical Innovations Holdings Ltd Warrants (GMVDW) is $7.04 (NASDAQ) as of 22-Aug-2023 13:34 EDT. G Medical Innovations Holdings Ltd Warrants (GMVDW) has given a return of 122.26% in the last 1 years.
What is the current PB & PE ratio of G Medical Innovations Holdings Ltd Warrants (GMVDW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-- |
-- |
2021 |
-0.22 |
-0.55 |
2020 |
-- |
-- |
2019 |
-- |
-- |
2018 |
-- |
-- |
What is the 52 Week High and Low of G Medical Innovations Holdings Ltd Warrants (GMVDW)?
The 52-week high and low of G Medical Innovations Holdings Ltd Warrants (GMVDW) are Rs -- and Rs -- as of 15-Sep-2026.
What is the market cap of G Medical Innovations Holdings Ltd Warrants (GMVDW)?
G Medical Innovations Holdings Ltd Warrants (GMVDW) has a market capitalisation of -- as on 23-Aug-2023. As per SEBI classification, it is a company.
Should I invest in G Medical Innovations Holdings Ltd Warrants (GMVDW)?
Before investing in G Medical Innovations Holdings Ltd Warrants (GMVDW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.